Risk Scores Inform Prognosis, Not Prescriptions

Risk Scores Inform Prognosis, Not Prescriptions

A 15-minute microlearning activity on applying validated risk-stratification tools (MAP, Manhattan, Minnesota, MAGIC Composite) to inform prognosis, including NRM risk and treatment response, without using risk scores to direct routine first-line treatment decisions.

Price
Free
Provider
IQ Apparatus
Release date
August 17, 2026
Expires
July 22, 2027
Start activity

Credits

Learning objectives

Upon completion, participants should be able to:

  1. Apply current aGVHD staging, grading, and treatment-response criteria to assess disease severity and identify steroid-refractory disease.
  2. Evaluate clinical and biomarker-based risk-stratification tools to support aGVHD prognostication while recognizing their limitations in guiding routine treatment decisions.
  3. Determine when treatment escalation is appropriate for patients with steroid-refractory aGVHD based on current criteria and guideline recommendations.

Faculty